Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
56°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
GeneDx Holdings Corp. - Class A Common Stock
(NQ:
WGS
)
58.82
-0.27 (-0.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about GeneDx Holdings Corp. - Class A Common Stock
< Previous
1
2
3
Next >
The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts
October 16, 2024
Via
Benzinga
The Markets Are Ignoring Risk, But That Does Not Mean You Should...
September 29, 2024
It is Fall clean-up time. Sell lagging and sagging companies.
Via
Talk Markets
GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA Analytics
September 19, 2024
The company provides sequencing tools to help diagnose children with rare diseases.
Via
Investor's Business Daily
WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q2 2024
July 30, 2024
WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
July 18, 2024
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins.
Via
Benzinga
Expert Ratings For GeneDx Hldgs
July 17, 2024
Via
Benzinga
The Latest Analyst Ratings For GeneDx Hldgs
June 26, 2024
Via
Benzinga
Earnings Preview: GeneDx Hldgs
February 19, 2024
Via
Benzinga
7 Small-Cap Stocks With Massive Potential Returns
July 06, 2024
Explore these small-cap stocks with high potential in health care, REITs, entertainment, hardware, finance, and distribution industries.
Via
InvestorPlace
Over $12M Bet On PBF Energy? Check Out These 3 Stocks Insiders Are Buying
June 06, 2024
Via
Benzinga
Over $4M Bet On ProFrac Holding? Check Out These 3 Stocks Insiders Are Buying
May 29, 2024
Via
Benzinga
Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
May 16, 2024
Via
Benzinga
Gold Down Over 2%; 3M Profit Beats Expectations
April 30, 2024
Via
Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 30, 2024
Via
Benzinga
Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday
April 30, 2024
Via
Benzinga
Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 30, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 30, 2024
Our coverage for Tuesday starts with a dive into the biggest pre-market stock movers traders will want to keep an eye on today!
Via
InvestorPlace
WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q1 2024
April 29, 2024
WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
GeneDx Stock Climbs After Better-Than-Expected Q1 Results, Raises FY24 Guidance
April 29, 2024
GeneDx reports quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents by 50.75%. The company reported quarterly sales of $62.422 million which beat the...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 19, 2024
Via
Benzinga
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 18, 2024
Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 10, 2024
Via
Benzinga
Earnings Scheduled For February 20, 2024
February 20, 2024
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.